This clinical trial is focused on studying the effects of the medication oxytocin on healthy individuals. Oxytocin is a hormone that is often associated with social bonding and childbirth. In this study, it will be administered through an intravenous infusion, which means it will be given directly into the bloodstream. The trial will also use a placebo for comparison purposes. The main goal of the study is to understand how oxytocin affects the body’s sensory nerves, particularly those that respond to touch and inflammation.

Participants in the study will receive either oxytocin or a placebo and will undergo a series of tests to measure their sensory responses. These tests will include examining how the skin’s nerves react to touch and heat-induced inflammation. The study will also look at how oxytocin might influence cognitive functions, such as memory and information processing, as well as subjective experiences like the pleasantness of touch.

The trial is designed to be triple-blind, meaning that neither the participants, the researchers, nor the data analysts will know who is receiving oxytocin and who is receiving the placebo. This approach helps ensure that the results are unbiased. The study will take place over a short period, with participants being monitored closely to observe any changes in their sensory and cognitive responses. The findings from this research could provide valuable insights into the potential uses of oxytocin in medical treatments.